ALBADRY plus Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

albadry plus

zoetis belgium sa -

BIOCAN RABIES Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

biocan rabies

bioveta -

ORBENIN DC Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

orbenin dc

zoetis belgium sa -

ORBENIN EDC Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

orbenin edc

zoetis belgium sa -

RISPOVAL IBR Marker Inactivatum Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

rispoval ibr marker inactivatum

zoetis belgium sa rue laid burniat 1 1348 louvain -

BLUEVAC-4 Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bluevac-4

cz vaccines -

EURICAN DAPPi-L Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

eurican dappi-l

boehringer ingelheim animal health france scs 29 avenue tony garnier -

EURICAN DAPPi-LR Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

eurican dappi-lr

boehringer ingelheim animal health france scs 29 avenue tony garnier -

Suiseng Diff/A Evropska unija - slovenščina - EMA (European Medicines Agency)

suiseng diff/a

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - prašiči - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

Vaxneuvance Evropska unija - slovenščina - EMA (European Medicines Agency)

vaxneuvance

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pnevmokokne okužbe - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. glej poglavja 4. 4 in 5. 1 za informacije o zaščiti proti specifičnim pnevmokoknim serotipom. the use of vaxneuvance should be in accordance with official recommendations.